Genovis AB (FRA:5GV) Total Tax Payable : €0.00 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Genovis AB Total Tax Payable?

Genovis AB's Total Tax Payable for the quarter that ended in Sep. 2024 was €0.00 Mil.

Genovis AB Total Tax Payable Historical Data

The historical data trend for Genovis AB's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovis AB Total Tax Payable Chart

Genovis AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

Genovis AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Tax Payable	Get a 7-Day Free Trial															-	-	-	-	-

Genovis AB Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Genovis AB Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Genovis AB's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genovis AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (FRA:5GV) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

GENO:Sweden

Address

Scheelevagen 2, Box 790, Lund, SWE, SE-220 07

Website

https://www.genovis.com

Genovis AB provides enzymes and technologies for the analytical characterization and conjugation of biopharmaceuticals. The principal activities of the company are to develop, produce, and market tools for developing new drugs and diagnostics. Its product line comprises GingisREX, FabRICATOR, GlyCLICK, GingisKHAN, GlycINATOR, Fabulous, lgGZERO, and Enzymes for O-glycan. The company's main product category consists of Enzymes and Antibodies. Geographically its segments include Sweden and the rest of the world.

Genovis AB Headlines

No Headlines